It would then be interesting to develop in vitro and in vivo models to examine the role of these TPCN2 mutations during tumor formation (involving neoangiogenesis) and cancer-cell migration as well as their clinical utility as diagnostic or prognostic biomarkers in different cancers. Here, TPCN2 is linked to neoplasm.